1. Home
  2. CHPT vs EDAP Comparison

CHPT vs EDAP Comparison

Compare CHPT & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChargePoint Holdings Inc.

CHPT

ChargePoint Holdings Inc.

N/A

Current Price

$5.61

Market Cap

155.2M

ML Signal

N/A

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

N/A

Current Price

$4.14

Market Cap

163.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHPT
EDAP
Founded
2007
1979
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.2M
163.4M
IPO Year
2019
1998

Fundamental Metrics

Financial Performance
Metric
CHPT
EDAP
Price
$5.61
$4.14
Analyst Decision
Hold
Buy
Analyst Count
12
3
Target Price
$12.18
$8.50
AVG Volume (30 Days)
421.0K
64.3K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
47.54
N/A
EPS
N/A
N/A
Revenue
$417,083,000.00
N/A
Revenue This Year
$8.53
N/A
Revenue Next Year
$11.93
$7.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$1.21
52 Week High
$12.62
$5.05

Technical Indicators

Market Signals
Indicator
CHPT
EDAP
Relative Strength Index (RSI) 37.42 47.99
Support Level $5.60 $3.89
Resistance Level $6.76 $4.24
Average True Range (ATR) 0.35 0.34
MACD -0.02 -0.08
Stochastic Oscillator 20.30 43.06

Price Performance

Historical Comparison
CHPT
EDAP

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: